BioSpace News Archive

The industry analysis report is considered a valuable source of information about the global Laser Fiber In Medical industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

9 Meters Biopharma, Inc. today provided an overview of its recent achievements, important upcoming milestones, and financial results for the fourth quarter and full year ended December 31, 2021.

Mednow Inc. (“Mednow’’ or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is pleased to announce it has released its financial results for the period ending January 31st, 2022 (“Q2 2022”).

VectivBio Holding AG today announced new preclinical data supporting the potential of apraglutide, a next-generation, long-acting GLP-2 analog, as a novel treatment of steroid-refractory GI aGVHD following allogeneic hemopoietic stem cell transplant (HSCT).

Elysium Health, Inc.™, a leading life sciences company focused on aging research, has entered into a material transfer agreement with the University of Oxford to examine hundreds of samples from the VITACOG study to develop epigenetic measures of brain aging and health.

Merck announced today that Dr. Roy D. Baynes, head of Global Clinical Development (GCD) and Chief Medical Officer, Merck Research Laboratories (MRL), will be retiring from Merck in July.

TRACON Pharmaceuticals (NASDAQ: TCON), today announced that Charles Theuer, M.D., Ph.D., President and Chief Executive Officer, will participate in a fireside chat hosted by Jason McCarthy, at the Maxim Group 2022 Virtual Growth Conference.

Atreca, Inc. announced it will host a virtual R&D Day on Tuesday, April 5, 2022, at 4:15 p.m. EDT, focused on the Company’s preclinical pipeline programs in oncology.

Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that Walter Klemp, Chairman and CEO of Moleculin Biotech, will participate at the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest, taking place March 28-30, 2022.

Thermo Fisher Scientific Inc., the world leader in serving science, today announced its collaboration with the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) Initiative, Helix, and Rosalind aimed at developing a new genotyping method for SARS-CoV-2 that could speed up the identification of variants as they emerge.